Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Skin Neoplasms 1Pancreatic Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Cisplatin 3liposomal amphotericin B 2Therapeutics 2Radiotherapy 2Ifosfamide 2Etoposide 2Cyclophosphamide 2Bleomycin 2sargramostim 1aldesleukin 1Taxes 1Ribavirin 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Palivizumab 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Itraconazole 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-11 1Interferon-alpha 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fluconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma, Testicular × In Situ Hybridization × Genitourinary × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡